4th National Congress of the Bulgarian Society for Dermatologic Surgery, Sofia, 12th March 2022 with main topics: one step melanoma surgery and drug induced melanoma
https://doi.org/10.4081/dr.2022.9542
HTML: 17
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Not available
Tchernev G, Chokoeva AA. Melanoma in a Chinese dragon tattoo. Lancet 2022 ;399:e37. DOI: https://doi.org/10.1016/S0140-6736(15)01038-7
Tchernev G, Chokoeva AA. New Safety Margins for Melanoma Surgery: Nice Possibility for Drinking of "Just That Cup of Coffee"? Open Access Maced J Med Sci 2017;5:352-8. DOI: https://doi.org/10.3889/oamjms.2017.068
Tchernev G, Oliveira N, Kandathil LJ, Patterson JW. Personalised one step melanoma surgery with complete reciprocity between clinical and histopathological margins: a novel way to improve melanoma recurrence free-survival. J Medical Review (Bulgarian) 2022;58: 29-33.
Tchernev G, Kandathil LJ, Oliveira N. Intermediate thickness cutaneous mela-nomas and the new trends in dermatologic surgery: the advantages of personalized one step surgical approach. J Medical Review (Bulgarian) 2022;58:42-45.
Tchernev G, Malev V, Patterson JW, Lotti T. A novel surgical margin (1 cm) might be from benefit for patients with dysplastic nevi, thin melanomas, and melanoma in situ: Analysis based on clinical cases. Dermatol Ther 2020;33: e13261. DOI: https://doi.org/10.1111/dth.13261
Tchernev G, Poterov G, Malev V. The Future of Personalized Medicine: One Step Melanoma Surgery. Acta Medica Bulgarica 2020;47:52-7. DOI: https://doi.org/10.2478/amb-2020-0046
Tchernev G, Temelkova I. The One Step Melanoma Surgery (OSMS): A New Chance for More Adequate Surgical Treatment of Melanoma Patients!?Open Access Maced J Med Sci 2019;7:504-6. DOI: https://doi.org/10.3889/oamjms.2019.147
Tchernev G, Bitolska A, Patterson JW. Telmisartan (and/or nitrosamine) - induced occult melanoma: first reported case in world literature. Expert Rev Clin Pharmacol 2021;10:1-6. DOI: https://doi.org/10.1080/17512433.2021.1938547
Tchernev G, Patterson JW. Telmisartan/hydrochlorothiazide-induced nevus-associated cutaneous melanoma: first report in the medical litera-ture. Expert Rev Clin Pharmacol 2021;14:289-93. DOI: https://doi.org/10.1080/17512433.2021.1890581
US Food and Drug Administration. Information about Nitrosamine Impurities in Medications. 2021 Nov 11; [cited on 2022 June 8] Available on:https://www.fda.gov/drugs/drug-safety-and-availability/information-about-nitrosamine-impurities-medica-tions
Llamas M, 2021. Does Zantac Cause Cancer? Zantac Cancer Risk & Recall [cited 2022 May 24]. Available from: s-zantac-cause-cancer/https://www.drugwatch.com/zantac/doe
Chokoeva AA, Lozev I, Yungareva I, et al. Seborrheic Pemphigus, Antigen Mimicry and the Subsequent-Wrong Diagnostic and Therapeutic Approach?Open Access Maced J Med Sci 2018;6:128-1. DOI: https://doi.org/10.3889/oamjms.2018.011
Copyright (c) 2022 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
